The discovery of ROS1 fusion rearrangements—most notably the TFG::ROS1 oncoprotein—has transformed our understanding of inflammatory myofibroblastic tumor (IMT) biology [39]. The gene discussed is ROS1; the disease is inflammatory myofibroblastic tumor.